Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zivin, J. A.
Right arrow Articles by Venditto, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zivin, J. A.
Right arrow Articles by Venditto, J. A.
NEUROLOGY 1984;34:469
© 1984 American Academy of Neurology

Experimental CNS ischemia

Serotonin antagonists reduce or prevent damage

Justin A. Zivin, MD, PhD and John A. Venditto, BA

From the Department of Neurology, University of Massachusetts Medical Center, Worcester, MA.

We tested three serotonin antagonists-lysergic acid diethylamide (LSD), 2-bromolysergic acid diethylamide (BOL), and cinanserin — for effects on experimental spinal cord ischemia in the rabbit. Blood fiow to spinal cord was obstructed. Drugs were administered before or after initiation of occlusion, and flow was later restored. When LSD was given 5 minutes after the onset of occlusion, the duration of ischemia required to produce neurologic abnormality was prolonged, but this protection was temporary. BOL and cinanserin treatment 5 minutes after the onset of ischemia was beneficial because neurologic improvement was permanent, and pretreatment with these drugs also markedly reduced damage. Therefore, several serotonin antagonists can prevent or reduce spinal cord damage when administered before or after the onset of ischemia.

Address correspondence and reprint requests to Dr. Zivin, Department of Neurology, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01605.

Supported by PHS Grants NS 00456 and NS 15827.

Accepted for publication July 11, 1983.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
K. A. Naidu, E. S. Fu, E. T. Sutton, L. D. Prockop, and A. Cantor
The Therapeutic Effects of Epidural Intercellular Adhesion Molecule-1 Monoclonal Antibody in a Rabbit Model: Involvement of the Intercellular Adhesion Molecule-1 Pathway in Spinal Cord Ischemia
Anesth. Analg., September 1, 2003; 97(3): 857 - 862.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. I. Weintraub
Methysergide (Sansert) Treatment in Acute Stroke Community Pilot Study
Angiology, March 1, 1985; 36(3): 137 - 142.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by AAN Enterprises, Inc.